Apnimed (APMD) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $17.76, -2.68% vs the prior close of $18.25.
- Volume 235.05K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
APMD dips 2.7% to $17.76. Closed at $17.76, -2.68% vs the prior close of $18.25. Day range $17.40–$18.35, opened at $18.30.
APMD daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — APMD dips 2.7% to $17.76
- Closed at $17.76, -2.68% vs the prior close of $18.25. Day range $17.40–$18.35, opened at $18.30.
- Volume was 235.05K shares, 0.5x its 50-day average of 483.60K — lighter than usual.
- Price is -29.3% vs its 50-day average ($25.11).
- 52-week range $16.12–$35.29; today's close sits at 9% of that range, 49.7% below the 52-week high.
Oct 15, 2026 — APMD jumps 5.9% to $18.25
- Closed at $18.25, +5.92% vs the prior close of $17.23. Day range $17.25–$18.76, opened at $17.25.
- Volume was 260.20K shares, 0.5x its 50-day average of 488.12K — lighter than usual.
- Price is -27.9% vs its 50-day average ($25.32).
- 52-week range $16.12–$35.29; today's close sits at 11% of that range, 48.3% below the 52-week high.
Oct 14, 2026 — APMD slides 3.4% to $17.23, a 1-month low on 2.1x normal volume
- Closed at $17.23, -3.37% vs the prior close of $17.83. Day range $17.00–$18.62, opened at $17.85.
- Volume was 1.01M shares, 2.1x its 50-day average of 473.83K — unusually heavy trading.
- Price is -32.4% vs its 50-day average ($25.48).
- 52-week range $16.12–$35.29; today's close sits at 6% of that range, 51.2% below the 52-week high.
Oct 13, 2026 — APMD slides 4.3% to $17.83, a 1-month low
- Closed at $17.83, -4.29% vs the prior close of $18.63. Day range $17.45–$18.85, opened at $18.85.
- Volume was 215.60K shares, 0.4x its 50-day average of 483.52K — lighter than usual.
- Price is -30.5% vs its 50-day average ($25.65).
- 52-week range $16.12–$35.29; today's close sits at 9% of that range, 49.5% below the 52-week high.
Oct 12, 2026 — APMD rises 0.6% to $18.63, 3 up days in a row
- Closed at $18.63, +0.59% vs the prior close of $18.52. Day range $18.26–$20.00, opened at $18.57.
- Volume was 301.10K shares, 0.6x its 50-day average of 546.39K — lighter than usual.
- Price is -27.8% vs its 50-day average ($25.80).
- 52-week range $16.12–$35.29; today's close sits at 13% of that range, 47.2% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — APMD rises 1.6% to $18.52
- Closed at $18.52, +1.65% vs the prior close of $18.22. Day range $17.80–$19.54, opened at $18.18.
- Volume was 268.30K shares, 0.5x its 50-day average of 552.07K — lighter than usual.
- Price is -28.6% vs its 50-day average ($25.92).
- 52-week range $16.12–$35.29; today's close sits at 13% of that range, 47.5% below the 52-week high.
Oct 8, 2026 — APMD rises 1.0% to $18.22
- Closed at $18.22, +1.00% vs the prior close of $18.04. Day range $17.38–$18.61, opened at $18.05.
- Volume was 332.00K shares, 0.6x its 50-day average of 556.65K — lighter than usual.
- 52-week range $16.12–$35.29; today's close sits at 11% of that range, 48.4% below the 52-week high.
Oct 7, 2026 — APMD slides 3.3% to $18.04, a 1-month low
- Closed at $18.04, -3.27% vs the prior close of $18.65. Day range $17.84–$19.40, opened at $18.66.
- Volume was 465.60K shares, 0.8x its 50-day average of 558.59K.
- 52-week range $16.12–$35.29; today's close sits at 10% of that range, 48.9% below the 52-week high.
Oct 6, 2026 — APMD slides 14.3% to $18.65, a 1-month low
- Closed at $18.65, -14.25% vs the prior close of $21.75. Day range $18.34–$21.95, opened at $21.95.
- Volume was 580.80K shares, 1.0x its 50-day average of 558.11K.
- 52-week range $16.12–$35.29; today's close sits at 13% of that range, 47.2% below the 52-week high.
Oct 5, 2026 — APMD rises 1.1% to $21.75
- Closed at $21.75, +1.12% vs the prior close of $21.51. Day range $21.10–$22.11, opened at $21.70.
- Volume was 340.30K shares, 0.6x its 50-day average of 562.95K.
- 52-week range $16.12–$35.29; today's close sits at 29% of that range, 38.4% below the 52-week high.
Oct 2, 2026 — APMD slides 4.6% to $21.51
- Closed at $21.51, -4.57% vs the prior close of $22.54. Day range $21.10–$22.73, opened at $22.60.
- Volume was 681.80K shares, 1.2x its 50-day average of 560.25K.
- 52-week range $16.12–$35.29; today's close sits at 28% of that range, 39.0% below the 52-week high.
APMD latest news & SEC filings
Every SEC filing by or about APMD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 8, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Sep 8, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $12.08M (prior year $17.11M) (-29.4% vs Jun 30, 2025)
- Net income: $125.94M (prior year -$69.47M) (swung to profit vs Jun 30, 2025)
Sep 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 7, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Morningside Venture Investments Ltd bought 312,500 shares at $16.00 (≈$5.00M) on Aug 3, 2026
- Morningside Venture Investments Ltd bought 312,500 shares at $16.00 (≈$5.00M) on Aug 3, 2026
- Morningside Venture Investments Ltd bought 312,500 shares at $16.00 (≈$5.00M) on Aug 3, 2026
- Morningside Venture Investments Ltd bought 312,500 shares at $16.00 (≈$5.00M) on Aug 3, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Jul 31, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Jul 31, 2026 · Form 424B4 — Final prospectus with offering price
Final prospectus with offering price
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 30, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Things to know before you trade APMD
- Last results release: Sep 8, 2026 (8-K Item 2.02).
- How much it moves: over the last 20 sessions the average daily move was 4.87% (largest 14.3%). That is a volatile stock.
- Liquidity: about 537.45K shares (≈$9.55M) trade per day on average.
- 52-week position: $17.76 vs a range of $16.12–$35.29 (9% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 0 sales; latest: Venture Investments Ltd Morningside bought 312,500 shares on Aug 3, 2026.
- Latest filings: 10-Q Sep 8, 2026; 8-K Sep 8, 2026; 8-K Aug 3, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
APMD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 18.30 | 18.35 | 17.40 | 17.76 | 235.05K |
| Oct 15, 2026 | 17.25 | 18.76 | 17.25 | 18.25 | 260.20K |
| Oct 14, 2026 | 17.85 | 18.62 | 17.00 | 17.23 | 1.01M |
| Oct 13, 2026 | 18.85 | 18.85 | 17.45 | 17.83 | 215.60K |
| Oct 12, 2026 | 18.57 | 20.00 | 18.26 | 18.63 | 301.10K |
| Oct 9, 2026 | 18.18 | 19.54 | 17.80 | 18.52 | 268.30K |
| Oct 8, 2026 | 18.05 | 18.61 | 17.38 | 18.22 | 332.00K |
| Oct 7, 2026 | 18.66 | 19.40 | 17.84 | 18.04 | 465.60K |
| Oct 6, 2026 | 21.95 | 21.95 | 18.34 | 18.65 | 580.80K |
| Oct 5, 2026 | 21.70 | 22.11 | 21.10 | 21.75 | 340.30K |
| Oct 2, 2026 | 22.60 | 22.73 | 21.10 | 21.51 | 681.80K |
| Oct 1, 2026 | 21.96 | 24.50 | 21.96 | 22.54 | 747.40K |
| Sep 30, 2026 | 23.57 | 24.50 | 21.49 | 21.91 | 668.80K |
| Sep 29, 2026 | 21.48 | 24.29 | 21.48 | 23.90 | 669.50K |
| Sep 28, 2026 | 21.15 | 22.09 | 19.80 | 21.67 | 283.80K |
| Sep 25, 2026 | 22.00 | 22.77 | 20.68 | 21.09 | 298.70K |
| Sep 24, 2026 | 22.06 | 22.85 | 20.50 | 21.63 | 398.20K |
| Sep 23, 2026 | 25.44 | 25.44 | 21.60 | 22.49 | 858.10K |
| Sep 22, 2026 | 26.41 | 26.69 | 24.42 | 25.51 | 624.00K |
| Sep 21, 2026 | 28.90 | 28.90 | 23.13 | 26.22 | 1.51M |
About Apnimed
Apnimed (APMD) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in CAMBRIDGE, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1745648.
APMD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Chris Dimitropoulos | Director | Jul 30, 2026 |
| Paul R. Fonteyne | Director | Aug 3, 2026 |
| William A Jr Jones | Director | Aug 3, 2026 |
| Kevin Robert Lind | Chief Executive Officer | Aug 3, 2026 |
| Lawrence G. Miller | Director | Aug 3, 2026 |
| Paul J Sekhri | Director | Aug 3, 2026 |
| Gary Sender | Director | Aug 3, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Michael B Kelly | Chief Financial Officer | Aug 3, 2026 |
| Kevin Robert Lind | Chief Executive Officer | Aug 3, 2026 |
| Dennis Patrick Molnar | President | Aug 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 3, 2026 | Venture Investments Ltd Morningside | Buy | 312,500 | $16.00 |
| Aug 3, 2026 | Venture Investments Ltd Morningside | Buy | 312,500 | $16.00 |
| Aug 3, 2026 | Venture Investments Ltd Morningside | Buy | 312,500 | $16.00 |
| Aug 3, 2026 | Venture Investments Ltd Morningside | Buy | 312,500 | $16.00 |
| Aug 3, 2026 | Paul J Sekhri | Buy | 12,500 | $16.00 |
| Aug 3, 2026 | Paul J Sekhri | Buy | 12,500 | $16.00 |
| Aug 3, 2026 | Paul J Sekhri | Buy | 12,500 | $16.00 |
| Aug 3, 2026 | Paul J Sekhri | Buy | 12,500 | $16.00 |
APMD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $195.46M, total liabilities $125.70M, cash $172.80M (as of Jun 30, 2026).
APMD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Sep 8, 2026 | 8-K Item 2.02 (results) | $28.79 |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on APMD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.